5-Hydroxy-N,N-morpholinyltryptamine
| 5-HO-mor-T | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 246.30 g/mol [1] |
| Predicted LogP | 0.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C14H18N2O2 |
| IUPAC name | 3-(2-morpholin-4-ylethyl)-1H-indol-5-ol |
| SMILES | C1COCCN1CCC2=CNC3=C2C=C(C=C3)O |
| InChI | InChI=1S/C14H18N2O2/c17-12-1-2-14-13(9-12)11(10-15-14)3-4-16-5-7-18-8-6-16/h1-2,9-10,15,17H,3-8H2 |
| InChIKey | MHFSFVWWHDYPLD-UHFFFAOYSA-N |
| PubChem CID | 568010 |
5-Hydroxy-N,N-morpholinyltryptamine (also known as 3-[2-(4-Morpholinyl)ethyl]-1H-indol-5-ol # or 5-Hydroxy-3-(2-morpholinoethyl)indole) is a substance of the tryptamine and morpholinylethylindole class.
Chemistry
Stereochemistry []
5-Hydroxy-N,N-morpholinyltryptamine is achiral.
Druglikeness
Lipinski's rule of five
5-Hydroxy-N,N-morpholinyltryptamine matches Lipinski's rule of five.External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 568010, 5-Hydroxy-N,N-morpholinyltryptamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/568010
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 12:23:51 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 12:23:47 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 12:23:47 |
| gsrs | missing (no UNII) | 2026-11-20 12:23:47 |
| hmdb | missing (no HMDB id) | 2026-11-20 12:23:47 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 12:23:50 |
| pubchem | ok | 2026-11-20 12:23:46 |
| missing (no r/tripreports posts mention it) | 2026-11-20 12:23:47 | |
| sider | missing (not in SIDER) | 2026-11-20 12:23:47 |
| structure | ok | 2026-11-20 12:23:47 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 12:23:47 |